Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois Chicago
The aim of this research is to evaluate the safety and efficacy of the use of the Lap-Band system in the morbidly obese adolescent population in the United States. We also propose to take advantage of the opportunity for liver biopsy and the data collected for the FDA study in adolescents to answer several questions: 1) what is the true incidence of non-alcoholic fatty liver disease (NAFLD) and its variants in morbidly obese adolescents; 2) what is the course of the NAFLD disease in adolescents who have undergone weight loss, including the progression from steatosis to NASH/ fibrosis or the progression of NASH to cirrhosis? 3) What are the factors implicated in this progression and 4) Is there a link between the excess visceral fat, MS and NAFLD as assessed by parallel changes in metabolic syndrome (MS) and NAFLD following weight loss intervention. The LAPBAND may provide obese adolescents with a significantly less morbid and reversible surgical option for weight loss.
Age
14–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ages 14 through 17
BMI greater than 40
BMI 35 to 40 and also having an obesity related comorbidity
Have a history of working in a multidisciplinary weight loss program utilizing nutritional training, behavior modification, and activity training
You may not be if
Subject history of congenital or acquired anomalies fo the gastrointestinal tract
Severe cardiopulmonary or other serious organic disease
Severe coagulopathy
Hepatic insufficiency or cirrhosis
History of bariatric gastric or esophageal surgery
History of intestinal obstruction or adhesive peritonitis